Status:
COMPLETED
Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness
Lead Sponsor:
Altitude Physiology Expeditions
Collaborating Sponsors:
University of Edinburgh
Conditions:
Acute Mountain Sickness
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), and high altitude cerebral edema (HACE) are complications of rapid ascent to high altitude. Several features suggest that raised in...
Detailed Description
Acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), and high altitude cerebral edema (HACE) are complications of rapid ascent to high altitude. By definition, AMS is a benign conditio...
Eligibility Criteria
Inclusion
- Participants in Apex 2 trial
Exclusion
- High altitude pulmonary oedema (HAPE)
- Gasto-intestinal illness
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT00664001
Start Date
March 1 2003
End Date
December 1 2003
Last Update
April 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Edinburgh
Edinburgh, United Kingdom